This study’s results identified 16 variants primarily located in genes such as GCKR, MON1A, and LPL that were independently associated with MASLD at genome-wide significance levels and determined differences in genetic variants between MASLD and NAFLD. The gene discussed is LPL; the disease is metabolic dysfunction-associated steatotic liver disease.